{"id":"W2605943665","doi":"10.1182/blood.v128.22.1218.1218","title":"Dynamo: A Phase 2 Study Demonstrating the Clinical Activity of Duvelisib in Patients with Relapsed Refractory Indolent Non-Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Cégep de l'Outaouais; Jewish General Hospital","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Adverse effect; Refractory (planetary science); Phases of clinical research; Lymphoma; Clinical endpoint; Oncology; Regimen; Salvage therapy; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":{"n_in":0,"stratum":"aff_core","weight":5595.2375,"opus":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Phase 2 clinical trial of duvelisib in lymphoma; a clinical efficacy question."},"gpt":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"This reports a clinical trial of lymphoma treatment, not research itself."},"grok":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Phase 2 clinical trial of duvelisib in indolent lymphoma; therapeutic efficacy, not research practice."}}}